Mark Acosta
Impact in
- Dermatology top 5%
- Cutaneous lymphoproliferative disorders research
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 8
-
- T-cell and Retrovirus Studies 7
- Toxin Mechanisms and Immunotoxins 1
- Co-authors
- Madeleine Duvic (2 shared papers)H. Miles Prince (1 shared paper)A. Negro‐Vilar (1 shared paper)Wolfram Sterry (1 shared paper)Ann Martin (1 shared paper)David J. Straus (1 shared paper)Chalid Assaf (1 shared paper)Yijun Sun (1 shared paper)
- Journals
- Blood (6 papers)Circulation (1 paper)Journal of Clinical Oncology (1 paper)Pediatric Emergency Care (1 paper)American Journal of Hematology (1 paper)
- Partner nations
- United StatesItalyFrance
In The Last Decade
Mark Acosta
16 papers receiving 309 citations
Peers
Comparison fields: 5 of 50
- Dermatology 142
- Pathology and Forensic Medicine 142
- Immunology 115
- Anesthesiology and Pain Medicine 21
- Oncology 67
Countries citing papers authored by Mark Acosta
This map shows the geographic impact of Mark Acosta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Acosta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Acosta more than expected).
Fields of papers citing papers by Mark Acosta
This network shows the impact of papers produced by Mark Acosta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Acosta. The network helps show where Mark Acosta may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Acosta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 155 | |
| 2 | 2000 | 31 | |
| 3 | 2003 | 28 | |
| 4 | 2019 | 27 | |
| 5 | Use of the preoperative levels of CEA in patients with colorectal cancer. | 2003 | 16 |
| 6 | 2007 | 13 | |
| 7 | 2020 | 12 | |
| 8 | 2020 | 9 | |
| 9 | 2006 | 6 | |
| 10 | 2016 | 5 | |
| 11 | 2019 | 5 | |
| 12 | 2006 | 4 | |
| 13 | Pharmacokinetics and safety of intramuscular injection of concentrated certriaxone in children. | 1992 | 4 |
| 14 | 2018 | 2 | |
| 15 | 2024 | 1 | |
| 16 | 2016 | 1 |
About Mark Acosta
Mark Acosta is a scholar working on Pathology and Forensic Medicine, Immunology, Dermatology, Oncology and Molecular Biology, having authored 16 papers that have together received 319 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (8 papers), T-cell and Retrovirus Studies (7 papers), Cutaneous lymphoproliferative disorders research (6 papers), CAR-T cell therapy research (3 papers), Glycosylation and Glycoproteins Research (1 paper), Opioid Use Disorder Treatment (1 paper), Toxin Mechanisms and Immunotoxins (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Dermatology (142 citations), Pathology and Forensic Medicine (142 citations), Immunology (115 citations), Anesthesiology and Pain Medicine (21 citations) and Oncology (67 citations). Mark Acosta has collaborated with scholars based in United States, Italy and France. Frequent co-authors include Madeleine Duvic, H. Miles Prince, A. Negro‐Vilar, Wolfram Sterry, Ann Martin, David J. Straus, Chalid Assaf, Yijun Sun, John T. Kanegaye and David Bank. Their work appears in journals such as Blood, Circulation, Journal of Clinical Oncology, Pediatric Emergency Care and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.